According to a recent CDC survey, one in four cancer survivors struggle to pay their medical bills. An even higher number worry about whether they’ll be able to scrounge up the money to pay off their out-of-pocket healthcare costs.
I’m quite comfortable blaming the healthcare industry, writ large, for this problem. Healthcare prices in the United States are outrageously high. The cost of cancer care in particular is often unjustifiably burdensome, with new chemotherapies typically coming to market at prices exceeding $100,000 per patient even when they yield pretty modest health benefits.
(To read the rest of the article, please visit Forbes.)